Pricing Log in Create free account

Werewolf Therapeutics, Inc. (HOWL) vs iBio, Inc. (IBIO)

Werewolf Therapeutics, Inc. and iBio, Inc. are both Biotechnology companies. Werewolf Therapeutics, Inc. and iBio, Inc. are of similar size ($48.5M and $47.6M). Werewolf Therapeutics, Inc. grew revenue faster over the last twelve months: −5.21% against −66.6%. iBio, Inc. has the higher net margin (0.00% vs −141.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, iBio, Inc. leads on 11 and Werewolf Therapeutics, Inc. on 3.

Valuation

Metric HOWL IBIO Biotechnology median
P/E n/m n/m 8.50
P/S 1.95 118.71 9.71
P/B 2.92 0.93 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.19 0.64
EV/Sales 1.94 (9.70) 9.21
Earnings yield (74.49%) (44.16%) (33.15%)
Free cash flow yield (62.73%) (30.24%) (25.50%)

Profitability

Metric HOWL IBIO Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (128.18%) 0.00% 0.00%
Net margin (141.94%) 0.00% 0.00%
Free cash flow margin (122.51%) 0.00% 0.00%
Return on equity (119.86%) (65.70%) (56.36%)
Return on assets (59.31%) (54.04%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HOWL IBIO Biotechnology median
Revenue growth (TTM) (5.21%) (66.55%) 6.02%
EPS growth (last fiscal year) 18.40% 81.71% 30.26%
Revenue growth, 5-year CAGR — (42.83%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HOWL IBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.91 7.85 4.72
Net debt to EBITDA 0.97 2.57 0.96

Dividend

Metric HOWL IBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HOWL IBIO Biotechnology median
Market cap 48.46m 47.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack